These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37726067)

  • 41. Epithelioid fibrous histiocytoma: three diagnostically challenging cases with novel ALK gene fusions, unusual storiform growth pattern, and a prominent spindled morphology.
    Mansour B; Donati M; Michalová K; Michal M; Ptáková N; Hájková V; Michal M
    Virchows Arch; 2022 Nov; 481(5):751-757. PubMed ID: 36171493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights.
    Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
    Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case report of epithelioid inflammatory myofibroblastic sarcoma with RANBP2-ALK fusion gene treated with the ALK inhibitor, crizotinib.
    Kimbara S; Takeda K; Fukushima H; Inoue T; Okada H; Shibata Y; Katsushima U; Tsuya A; Tokunaga S; Daga H; Okuno T; Inoue T
    Jpn J Clin Oncol; 2014 Sep; 44(9):868-71. PubMed ID: 25028698
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy.
    Hornick JL; Jaffe ES; Fletcher CD
    Am J Surg Pathol; 2004 Sep; 28(9):1133-44. PubMed ID: 15316312
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma.
    Jiang Q; Tong HX; Hou YY; Zhang Y; Li JL; Zhou YH; Xu J; Wang JY; Lu WQ
    Orphanet J Rare Dis; 2017 May; 12(1):97. PubMed ID: 28535796
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel fusion sarcomas including targetable NTRK and ALK.
    Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC
    Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib.
    Mansfield AS; Murphy SJ; Harris FR; Robinson SI; Marks RS; Johnson SH; Smadbeck JB; Halling GC; Yi ES; Wigle D; Vasmatzis G; Jen J
    Ann Oncol; 2016 Nov; 27(11):2111-2117. PubMed ID: 27742657
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epithelioid inflammatory myofibroblastic sarcoma treated with ALK inhibitor: a case report and review of literature.
    Liu Q; Kan Y; Zhao Y; He H; Kong L
    Int J Clin Exp Pathol; 2015; 8(11):15328-32. PubMed ID: 26823889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal Adenocarcinomas Harboring ALK Fusion Genes: A Clinicopathologic and Molecular Genetic Study of 12 Cases and Review of the Literature.
    Lasota J; Chłopek M; Wasąg B; Kowalik A; Christiansen J; Lamoureux J; Kuźniacka A; Felisiak-Gołąbek A; Liu Y; Reyes TAR; Saha R; Agaimy A; Behenska K; Biernat W; Cattaneo L; Centonze G; Daum O; Daumova M; Domagała P; Dziuba I; Geppert CE; Góźdź S; Nasierowska-Guttmejer A; Hałoń A; Hartmann A; Inaguma S; Iżycka-Świeszewska E; Kaczorowski M; Kołos M; Kopczyński J; Michal M; Milione M; Okoń K; Pęksa R; Pyzlak M; Ryś J; Waloszczyk P; Wejman J; Miettinen M
    Am J Surg Pathol; 2020 Sep; 44(9):1224-1234. PubMed ID: 32804454
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epithelioid sarcoma-like hemangioendothelioma.
    Billings SD; Folpe AL; Weiss SW
    Am J Surg Pathol; 2003 Jan; 27(1):48-57. PubMed ID: 12502927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
    Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
    Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A case report: Pharmacology and resistance patterns of three generations of ALK inhibitors in metastatic inflammatory myofibroblastic sarcoma.
    Parker BM; Parker JV; Lymperopoulos A; Konda V
    J Oncol Pharm Pract; 2019 Jul; 25(5):1226-1230. PubMed ID: 29925295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anaplastic Large-cell Lymphoma Involving Gastrointestinal Tract: A Clinicopathologic Study of 25 Cases of a Rare Tumor at a Rare Site.
    Ud Din N; Rahim S; Ansar Z; Ahmed A; Ahmad Z
    Int J Surg Pathol; 2023 Oct; 31(7):1195-1205. PubMed ID: 36514288
    [No Abstract]   [Full Text] [Related]  

  • 56. Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing.
    Walther C; Hofvander J; Nilsson J; Magnusson L; Domanski HA; Gisselsson D; Tayebwa J; Doyle LA; Fletcher CD; Mertens F
    Lab Invest; 2015 Sep; 95(9):1071-6. PubMed ID: 26121314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spitz nevus with EHBP1-ALK fusion and distinctive membranous localization of ALK.
    Bahrani E; Kunder CA; Teng JM; Brown RA; Rieger KE; Novoa RA; Cloutier JM
    J Cutan Pathol; 2022 Jun; 49(6):584-588. PubMed ID: 35113459
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular investigation of ALK-rearranged epithelioid fibrous histiocytomas identifies CLTC as a novel fusion partner and evidence of fusion-independent transcription activation.
    Georgantzoglou N; Green D; Winnick KN; Sumegi J; Charville GW; Bridge JA; Linos K
    Genes Chromosomes Cancer; 2022 Aug; 61(8):471-480. PubMed ID: 35289445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epithelioid inflammatory myofibroblastic sarcoma: a pitfall in the differential diagnosis of ALK-positive anaplastic large cell lymphoma.
    Fadl A; Feldman AL
    J Hematop; 2023 Jun; 16(2):125-126. PubMed ID: 37398940
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.